hotspot -WSS

hotspot

author：fashion 2025-09-28 23:30:06 - browse：89

An illustrated portrait of Eli Lilly's David Ricks and Skovronsky – biotech and pharma coverage from STAT — Eli Lilly CEO David Ricks (left) and Chief Scientific Officer Daniel S. Skovronsky Molly Ferguson for STAT

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition.

At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. But what struck Ricks was not the company’s technology, for imaging Alzheimer’s plaques, but Avid’s CEO, Daniel S. Skovronsky.

“Dan’s different,” Ricks told STAT. “I had this sense immediately. Some people get in biotech for the cha-ching.” Skovronsky turned out to be a secret weapon. Within six months, Ricks had been promoted to run Lilly’s biomedicine unit and Skovronsky was working for him.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Washington mulls new rules to avert another Change Healthcare

explore

WSS

Patient advocates debate FDA's accelerated approval process

BIO selects John Crowley as new CEO

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Covid vaccine financial winners and losers, from Pfizer to Novavax

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

BIO selects John Crowley as new CEO

hotspot

hotspot

Wikipedia

Tori Bowie and the unacceptable rates of Black maternal death

BIO selects John Crowley as new CEO

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: Merck, Vertex, and Viking updates

23andMe had bad news about my health. I wish a person had delivered it

There's no autism epidemic. It's an autism diagnosis epidemic

In age of alternative facts, a scholarly course on calling out crap

What don’t we know about an Alzheimer’s drug side effect?

Peter Hotez and the public health issue of online harassment

ReNAgade cuts staff seven months after raising $300 million

knowledge

J&J to emphasize cancer drugs, stop much of its vaccine research

Diagnostic tests are hitting their mathematical limits

Will the market for weight loss drugs really reach $100 billion?

J&J to emphasize cancer drugs, stop much of its vaccine research

As biotech industry slumps, bioscience job market is upside down

Takeda, Janssen join wearable maker to measure scratching

Wikipedia

leisure time

explore

Wikipedia